Literature DB >> 19578024

Differential effects of TGFbeta and vitreous on the transformation of retinal pigment epithelial cells.

Sunil K Parapuram1, Binyue Chang, Lei Li, Ren A Hartung, Kakarla V Chalam, Joyce U Nair-Menon, D Margaret Hunt, Richard C Hunt.   

Abstract

PURPOSE: In proliferative vitreoretinopathy retinal pigment epithelial (RPE) cells undergo epithelial-mesenchymal transformation (EMT). Vitreous and transforming growth factor-beta (TGFbeta) have been implicated in this EMT. The role of TGFbeta in the vitreous-mediated transformation of low-passage human RPE cells was investigated.
METHODS: Cells were treated with vitreous or TGFbeta2. SB431542 was used to inhibit TGFbeta signaling. Morphology was investigated using phase-contrast or confocal microscopy. Motility was measured using a monolayer-wounding assay. Invasion was determined using basement membrane matrix-based assays. Gene expression was measured by quantitative PCR, immunohistochemistry, or immunoblotting.
RESULTS: Changes in phosphorylation or cellular localization of Smad -2, -3, or -4 indicated a TGFbeta-like activity in vitreous. Cortical actin filaments in untreated cells were replaced by stress fibers after TGFbeta treatment, but peripheral actin aggregates were seen in vitreous-treated cells. SB431542 did not block the morphologic change induced by vitreous. Vitreous-treated cells exhibited increased motility and invasion, whereas TGFbeta-treated cells did not. However, SB431542 decreased vitreous-meditated changes in motility and invasion. The levels of mRNA for genes indicative of myofibroblast differentiation (alpha-SMA and CTGF) were increased by treatment with TGFbeta but suppressed by vitreous. TGFbeta or vitreous caused increased expression of Snail1.
CONCLUSIONS: Vitreous or TGFbeta caused a fibroblast-like morphology and induced Snail1, a marker of EMT. TGFbeta activity in vitreous was necessary but not sufficient for the vitreous-induced motile, invasive phenotype. However, differences in the cytoskeletal organization and in the expression of CTGF and alpha-SMA suggested that TGFbeta-treatment caused differentiation along a myofibroblast pathway, whereas vitreous treatment suppressed myofibroblast formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578024     DOI: 10.1167/iovs.09-3621

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

1.  The effects of pleiotrophin in proliferative vitreoretinopathy.

Authors:  Xue Ding; Yujing Bai; Xuemei Zhu; Tianqi Li; Enzhong Jin; Lvzhen Huang; Wenzhen Yu; Mingwei Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-12       Impact factor: 3.117

2.  Combined silencing of TGF-β2 and Snail genes inhibit epithelial-mesenchymal transition of retinal pigment epithelial cells under hypoxia.

Authors:  Zhuolei Feng; Ruishu Li; Huanqi Shi; Wenjiao Bi; Wenwen Hou; Xiaomei Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-21       Impact factor: 3.117

3.  Effects of transforming growth factor β2 and connective tissue growth factor on induction of epithelial mesenchymal transition and extracellular matrix synthesis in human lens epithelial cells.

Authors:  Cheng Pei; Bo Ma; Qian-Yan Kang; Li Qin; Li-Jun Cui
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

4.  The influence of systemic renin-angiotensin-inhibition on ocular cytokines related to proliferative vitreoretinopathy.

Authors:  Robert Hoerster; Sascha Fauser; Claus Cursiefen; Bernd Kirchhof; Ludwig M Heindl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-09       Impact factor: 3.117

5.  TGF-β2 secretion from RPE decreases with polarization and becomes apically oriented.

Authors:  Louis Hirsch; Hossein Nazari; Parameswaran G Sreekumar; Ram Kannan; Laurie Dustin; Danhong Zhu; Ernesto Barron; David R Hinton
Journal:  Cytokine       Date:  2014-12-10       Impact factor: 3.861

6.  Upregulation of TGF-ß1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition.

Authors:  Robert Hoerster; Philipp S Muether; Sarah Vierkotten; Manuel M Hermann; Bernd Kirchhof; Sascha Fauser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-17       Impact factor: 3.117

7.  Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy.

Authors:  Shikun He; Ernesto Barron; Keijiro Ishikawa; Hossein Nazari Khanamiri; Chris Spee; Peng Zhou; Satoru Kase; Zhuoshi Wang; Laurie Diane Dustin; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

8.  Effects of lentiviral RNA interference-mediated downregulation of integrin-linked kinase on biological behaviors of human lens epithelial cells.

Authors:  Yu-Ping Zheng; Shao-Bo Zhang; Feng Wang; Hui Liu; Wen Zhang; Bin Song; Zi-Yao Liu; Lei Xiong; Ya-Zhi Fan; Ding-Ying Liao
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

9.  Selective activation of p120ctn-Kaiso signaling to unlock contact inhibition of ARPE-19 cells without epithelial-mesenchymal transition.

Authors:  Hung-Chi Chen; Ying-Ting Zhu; Szu-Yu Chen; Scheffer C G Tseng
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

10.  Transcriptional factors associated with epithelial-mesenchymal transition in choroidal neovascularization.

Authors:  Manabu Hirasawa; Kousuke Noda; Setsuko Noda; Misa Suzuki; Yoko Ozawa; Kei Shinoda; Makoto Inoue; Yoko Ogawa; Kazuo Tsubota; Susumu Ishida
Journal:  Mol Vis       Date:  2011-05-06       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.